RSV Therapeutics Market: Monoclonal Antibodies Rewrite the Rules...

toegevoegd een audio Health

2026-10-27 06:11:42 - Translate -

RSV Therapeutics Market: Monoclonal Antibodies Rewrite the Rules of Infant Protection

Respiratory syncytial virus (RSV) is one of the most common causes of severe respiratory illness in infants and older adults. For decades, prevention options were limited and treatment was largely supportive. That landscape has transformed dramatically in recent years, with long-acting monoclonal antibodies and maternal vaccines entering clinical practice — and the respiratory syncytial...

0 Reacties 0 aandelen 120 Views 0 voorbeeld